Lori J. Wirth
0000-0002-2629-2289
8 papers found
Refreshing results…
Return of Vocal Fold Motion and Surgical Preservation of Invaded Recurrent Laryngeal Nerves After the Use of Neoadjuvant Therapy in Patients Presenting with Advanced Thyroid Cancer and Vocal Fold Paralysis: The Lazarus Effect
Challenges and strategies to combat resistance mechanisms in thyroid cancer therapeutics
Dabrafenib Versus Dabrafenib + Trametinib in BRAF-Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer: Results of a Randomized, Phase 2, Open-Label Multicenter Trial
Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer
Afirma Genomic Sequencing Classifier and Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers
Still Perfecting Radioiodine in Thyroid Cancer, After All These Years
Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT): Treatment-Emergent HTN With Lenvatinib in RR-DTC
Missing publications? Search for publications with a matching author name.